- Home
- XBP vs RNXT Comparison
XBP vs RNXT Comparison
Compare XBP & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBP
- RNXT
- Stock Information
- Founded
- XBP N/A
- RNXT 2012
- Country
- XBP United Kingdom
- RNXT United States
- Employees
- XBP N/A
- RNXT N/A
- Industry
- XBP Business Services
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- XBP Consumer Discretionary
- RNXT Health Care
- Exchange
- XBP Nasdaq
- RNXT Nasdaq
- Market Cap
- XBP 32.0M
- RNXT 31.0M
- IPO Year
- XBP N/A
- RNXT 2021
- Fundamental
- Price
- XBP $1.09
- RNXT $1.38
- Analyst Decision
- XBP
- RNXT Strong Buy
- Analyst Count
- XBP 0
- RNXT 2
- Target Price
- XBP N/A
- RNXT $6.50
- AVG Volume (30 Days)
- XBP 197.8K
- RNXT 96.3K
- Earning Date
- XBP 11-12-2024
- RNXT 11-13-2024
- Dividend Yield
- XBP N/A
- RNXT N/A
- EPS Growth
- XBP N/A
- RNXT N/A
- EPS
- XBP N/A
- RNXT N/A
- Revenue
- XBP $157,146,000.00
- RNXT N/A
- Revenue This Year
- XBP N/A
- RNXT N/A
- Revenue Next Year
- XBP N/A
- RNXT N/A
- P/E Ratio
- XBP N/A
- RNXT N/A
- Revenue Growth
- XBP N/A
- RNXT N/A
- 52 Week Low
- XBP $0.79
- RNXT $0.77
- 52 Week High
- XBP $5.55
- RNXT $1.86
- Technical
- Relative Strength Index (RSI)
- XBP 48.86
- RNXT 57.85
- Support Level
- XBP $0.98
- RNXT $1.27
- Resistance Level
- XBP $1.22
- RNXT $1.47
- Average True Range (ATR)
- XBP 0.21
- RNXT 0.12
- MACD
- XBP 0.00
- RNXT 0.00
- Stochastic Oscillator
- XBP 27.52
- RNXT 75.68
About XBP XBP Europe Holdings Inc.
XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.